Kim D. Blickenstaff
Independent DirectorMr. Kim D. Blickenstaff serves as an Independent Director at Nuvation Bio, Inc. since August 2019. He serves as a Director of OPY Acquisition Corp. I since October 2021. He served as Chair Emeritus of Tandem Diabetes Care Inc. since May 2024 and served as the Chairman of the Board at Tandem Diabetes Care Inc. since March 6, 2020 until February 2023. He served as Executive Chairman at Tandem Diabetes Care, Inc. since March 01, 2019 until March 6, 2020 and served as it’s the President and Chief Executive Officer since September 2007 until March 01, 2019. Mr. Blickenstaff has healthcare experience in finance, marketing management, sales and strategic planning. He has an extensive medical device and diagnostics experience. Mr. Blickenstaff served as Chairman and Chief Executive Officer of Biosite Incorporated, or Biosite, a provider of medical diagnostic products, from 1988 until its acquisition by Inverness Medical Innovations, Inc. in June 2007. He Co-founded Biosite Inc. and served as its Treasurer. He served as the President of Biosite Inc., from April 1988 to October 22, 2004 and also it’s Secretary from April 1988 to June 2002. He held various positions in finance, operations, research management, sales management, strategic planning and marketing with at Baxter Travenol, National Health Laboratories and Hybritech Inc. 'Hybritech'). He had been a Director of Tandem Diabetes Care, Inc. since September 2007 until May 22, 2024 and SenoRx, Inc. since March 2002. He joined the Tandem Diabetes Care, Inc. in September 2007. He serves as a Director of Orion Acquisition Corp. II, Micro Therapeutics, Inc. and MediSpectra Inc. He serves as a Director of Astute Medical, Inc. and several privately held medical products companies. He served as a Director at Predictive Biosciences, Inc. since February 2010. He served as a Director of Dexcom, Inc., from June 2001 to September 7, 2007. He has extensive experience overseeing the preparation of financial statements. He served as an Independent Director of Medivation, Inc., since 2005 until September 28, 2016. He served as a Director of Biosite Inc., since April 1988. He served as a Director of GeneOhm Sciences, Inc. He was a Certified Public Accountant. He received a B.A. in Political Science from Loyola University, Chicago and an M.B.A. from the Graduate School of Business of Loyola University, Chicago.
Positions
- Company NameNuvation Bio Inc.Stock CodeNUVBPositionIndependent DirectorColleagues
- DTDavid T. HungFounder, President, CEO & Chairman
- PPPhilippe Pierre SauvageCFO & Principal Financial Officer
- GHGary HattersleyChief Scientific Officer
- MMMoses MakunjeVP of Finance and Principal Accounting & Financial Officer
- DCDavid C. HanleyChief Technical Operations Officer
- WAWilliam Anthony VernonIndependent Director
- RBRobert B. BazemoreLead Independent Director
- KEKathryn E. FalbergIndependent Director
